Medical Care
Global Oral GLP-1 Market Research Report 2025
- May 12, 25
- ID: 237288
- Pages: 62
- Figures: 62
- Views: 14
The global market for Oral GLP-1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The main driving factors for oral GLP-1 receptor agonists are the following:
Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.
Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.
Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.
Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.
Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.
This report aims to provide a comprehensive presentation of the global market for Oral GLP-1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral GLP-1.
The Oral GLP-1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral GLP-1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral GLP-1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Novo Nordisk
Pfizer
AstraZeneca
Sanofi
Segment by Type
Sitagliptin
Saxagliptin
Alagliptin
Others
Segment by Application
Diabetics
Weight Loss People
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral GLP-1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The main driving factors for oral GLP-1 receptor agonists are the following:
Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.
Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.
Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.
Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.
Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.
This report aims to provide a comprehensive presentation of the global market for Oral GLP-1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral GLP-1.
The Oral GLP-1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral GLP-1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral GLP-1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Novo Nordisk
Pfizer
AstraZeneca
Sanofi
Segment by Type
Sitagliptin
Saxagliptin
Alagliptin
Others
Segment by Application
Diabetics
Weight Loss People
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral GLP-1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral GLP-1 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Alagliptin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral GLP-1 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetics
1.3.3 Weight Loss People
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral GLP-1 Market Perspective (2020-2031)
2.2 Global Oral GLP-1 Growth Trends by Region
2.2.1 Global Oral GLP-1 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral GLP-1 Historic Market Size by Region (2020-2025)
2.2.3 Oral GLP-1 Forecasted Market Size by Region (2026-2031)
2.3 Oral GLP-1 Market Dynamics
2.3.1 Oral GLP-1 Industry Trends
2.3.2 Oral GLP-1 Market Drivers
2.3.3 Oral GLP-1 Market Challenges
2.3.4 Oral GLP-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral GLP-1 Players by Revenue
3.1.1 Global Top Oral GLP-1 Players by Revenue (2020-2025)
3.1.2 Global Oral GLP-1 Revenue Market Share by Players (2020-2025)
3.2 Global Oral GLP-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral GLP-1 Revenue
3.4 Global Oral GLP-1 Market Concentration Ratio
3.4.1 Global Oral GLP-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral GLP-1 Revenue in 2024
3.5 Global Key Players of Oral GLP-1 Head office and Area Served
3.6 Global Key Players of Oral GLP-1, Product and Application
3.7 Global Key Players of Oral GLP-1, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral GLP-1 Breakdown Data by Type
4.1 Global Oral GLP-1 Historic Market Size by Type (2020-2025)
4.2 Global Oral GLP-1 Forecasted Market Size by Type (2026-2031)
5 Oral GLP-1 Breakdown Data by Application
5.1 Global Oral GLP-1 Historic Market Size by Application (2020-2025)
5.2 Global Oral GLP-1 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral GLP-1 Market Size (2020-2031)
6.2 North America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral GLP-1 Market Size by Country (2020-2025)
6.4 North America Oral GLP-1 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral GLP-1 Market Size (2020-2031)
7.2 Europe Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral GLP-1 Market Size by Country (2020-2025)
7.4 Europe Oral GLP-1 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral GLP-1 Market Size (2020-2031)
8.2 Asia-Pacific Oral GLP-1 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral GLP-1 Market Size (2020-2031)
9.2 Latin America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral GLP-1 Market Size by Country (2020-2025)
9.4 Latin America Oral GLP-1 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral GLP-1 Market Size (2020-2031)
10.2 Middle East & Africa Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral GLP-1 Introduction
11.1.4 Eli Lilly Revenue in Oral GLP-1 Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral GLP-1 Introduction
11.2.4 Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025)
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral GLP-1 Introduction
11.3.4 Pfizer Revenue in Oral GLP-1 Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Oral GLP-1 Introduction
11.4.4 AstraZeneca Revenue in Oral GLP-1 Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Oral GLP-1 Introduction
11.5.4 Sanofi Revenue in Oral GLP-1 Business (2020-2025)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral GLP-1 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Alagliptin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral GLP-1 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetics
1.3.3 Weight Loss People
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral GLP-1 Market Perspective (2020-2031)
2.2 Global Oral GLP-1 Growth Trends by Region
2.2.1 Global Oral GLP-1 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral GLP-1 Historic Market Size by Region (2020-2025)
2.2.3 Oral GLP-1 Forecasted Market Size by Region (2026-2031)
2.3 Oral GLP-1 Market Dynamics
2.3.1 Oral GLP-1 Industry Trends
2.3.2 Oral GLP-1 Market Drivers
2.3.3 Oral GLP-1 Market Challenges
2.3.4 Oral GLP-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral GLP-1 Players by Revenue
3.1.1 Global Top Oral GLP-1 Players by Revenue (2020-2025)
3.1.2 Global Oral GLP-1 Revenue Market Share by Players (2020-2025)
3.2 Global Oral GLP-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral GLP-1 Revenue
3.4 Global Oral GLP-1 Market Concentration Ratio
3.4.1 Global Oral GLP-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral GLP-1 Revenue in 2024
3.5 Global Key Players of Oral GLP-1 Head office and Area Served
3.6 Global Key Players of Oral GLP-1, Product and Application
3.7 Global Key Players of Oral GLP-1, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral GLP-1 Breakdown Data by Type
4.1 Global Oral GLP-1 Historic Market Size by Type (2020-2025)
4.2 Global Oral GLP-1 Forecasted Market Size by Type (2026-2031)
5 Oral GLP-1 Breakdown Data by Application
5.1 Global Oral GLP-1 Historic Market Size by Application (2020-2025)
5.2 Global Oral GLP-1 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral GLP-1 Market Size (2020-2031)
6.2 North America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral GLP-1 Market Size by Country (2020-2025)
6.4 North America Oral GLP-1 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral GLP-1 Market Size (2020-2031)
7.2 Europe Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral GLP-1 Market Size by Country (2020-2025)
7.4 Europe Oral GLP-1 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral GLP-1 Market Size (2020-2031)
8.2 Asia-Pacific Oral GLP-1 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral GLP-1 Market Size (2020-2031)
9.2 Latin America Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral GLP-1 Market Size by Country (2020-2025)
9.4 Latin America Oral GLP-1 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral GLP-1 Market Size (2020-2031)
10.2 Middle East & Africa Oral GLP-1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral GLP-1 Introduction
11.1.4 Eli Lilly Revenue in Oral GLP-1 Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral GLP-1 Introduction
11.2.4 Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025)
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral GLP-1 Introduction
11.3.4 Pfizer Revenue in Oral GLP-1 Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Oral GLP-1 Introduction
11.4.4 AstraZeneca Revenue in Oral GLP-1 Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Oral GLP-1 Introduction
11.5.4 Sanofi Revenue in Oral GLP-1 Business (2020-2025)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oral GLP-1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sitagliptin
Table 3. Key Players of Saxagliptin
Table 4. Key Players of Alagliptin
Table 5. Key Players of Others
Table 6. Global Oral GLP-1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oral GLP-1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Oral GLP-1 Market Share by Region (2020-2025)
Table 10. Global Oral GLP-1 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Oral GLP-1 Market Share by Region (2026-2031)
Table 12. Oral GLP-1 Market Trends
Table 13. Oral GLP-1 Market Drivers
Table 14. Oral GLP-1 Market Challenges
Table 15. Oral GLP-1 Market Restraints
Table 16. Global Oral GLP-1 Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Oral GLP-1 Market Share by Players (2020-2025)
Table 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)
Table 19. Ranking of Global Top Oral GLP-1 Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Oral GLP-1 Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Oral GLP-1, Headquarters and Area Served
Table 22. Global Key Players of Oral GLP-1, Product and Application
Table 23. Global Key Players of Oral GLP-1, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral GLP-1 Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Oral GLP-1 Revenue Market Share by Type (2020-2025)
Table 27. Global Oral GLP-1 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Oral GLP-1 Revenue Market Share by Type (2026-2031)
Table 29. Global Oral GLP-1 Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Oral GLP-1 Revenue Market Share by Application (2020-2025)
Table 31. Global Oral GLP-1 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Oral GLP-1 Revenue Market Share by Application (2026-2031)
Table 33. North America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Oral GLP-1 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly Company Details
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Oral GLP-1 Product
Table 51. Eli Lilly Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Novo Nordisk Company Details
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Oral GLP-1 Product
Table 56. Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 57. Novo Nordisk Recent Development
Table 58. Pfizer Company Details
Table 59. Pfizer Business Overview
Table 60. Pfizer Oral GLP-1 Product
Table 61. Pfizer Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Oral GLP-1 Product
Table 66. AstraZeneca Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Oral GLP-1 Product
Table 71. Sanofi Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 76. Authors List of This Report
List of Figures
Figure 1. Oral GLP-1 Picture
Figure 2. Global Oral GLP-1 Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral GLP-1 Market Share by Type: 2024 VS 2031
Figure 4. Sitagliptin Features
Figure 5. Saxagliptin Features
Figure 6. Alagliptin Features
Figure 7. Others Features
Figure 8. Global Oral GLP-1 Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral GLP-1 Market Share by Application: 2024 VS 2031
Figure 10. Diabetics Case Studies
Figure 11. Weight Loss People Case Studies
Figure 12. Others Case Studies
Figure 13. Oral GLP-1 Report Years Considered
Figure 14. Global Oral GLP-1 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Oral GLP-1 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Oral GLP-1 Market Share by Region: 2024 VS 2031
Figure 17. Global Oral GLP-1 Market Share by Players in 2024
Figure 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Oral GLP-1 Revenue in 2024
Figure 20. North America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Oral GLP-1 Market Share by Country (2020-2031)
Figure 22. United States Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Oral GLP-1 Market Share by Country (2020-2031)
Figure 26. Germany Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Oral GLP-1 Market Share by Region (2020-2031)
Figure 34. China Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Oral GLP-1 Market Share by Country (2020-2031)
Figure 42. Mexico Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Oral GLP-1 Market Share by Country (2020-2031)
Figure 46. Turkey Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 50. Novo Nordisk Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 52. AstraZeneca Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Oral GLP-1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sitagliptin
Table 3. Key Players of Saxagliptin
Table 4. Key Players of Alagliptin
Table 5. Key Players of Others
Table 6. Global Oral GLP-1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oral GLP-1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Oral GLP-1 Market Share by Region (2020-2025)
Table 10. Global Oral GLP-1 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Oral GLP-1 Market Share by Region (2026-2031)
Table 12. Oral GLP-1 Market Trends
Table 13. Oral GLP-1 Market Drivers
Table 14. Oral GLP-1 Market Challenges
Table 15. Oral GLP-1 Market Restraints
Table 16. Global Oral GLP-1 Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Oral GLP-1 Market Share by Players (2020-2025)
Table 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)
Table 19. Ranking of Global Top Oral GLP-1 Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Oral GLP-1 Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Oral GLP-1, Headquarters and Area Served
Table 22. Global Key Players of Oral GLP-1, Product and Application
Table 23. Global Key Players of Oral GLP-1, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral GLP-1 Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Oral GLP-1 Revenue Market Share by Type (2020-2025)
Table 27. Global Oral GLP-1 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Oral GLP-1 Revenue Market Share by Type (2026-2031)
Table 29. Global Oral GLP-1 Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Oral GLP-1 Revenue Market Share by Application (2020-2025)
Table 31. Global Oral GLP-1 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Oral GLP-1 Revenue Market Share by Application (2026-2031)
Table 33. North America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Oral GLP-1 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Oral GLP-1 Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Oral GLP-1 Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Oral GLP-1 Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Oral GLP-1 Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly Company Details
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Oral GLP-1 Product
Table 51. Eli Lilly Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Novo Nordisk Company Details
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Oral GLP-1 Product
Table 56. Novo Nordisk Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 57. Novo Nordisk Recent Development
Table 58. Pfizer Company Details
Table 59. Pfizer Business Overview
Table 60. Pfizer Oral GLP-1 Product
Table 61. Pfizer Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Oral GLP-1 Product
Table 66. AstraZeneca Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Oral GLP-1 Product
Table 71. Sanofi Revenue in Oral GLP-1 Business (2020-2025) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 76. Authors List of This Report
List of Figures
Figure 1. Oral GLP-1 Picture
Figure 2. Global Oral GLP-1 Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral GLP-1 Market Share by Type: 2024 VS 2031
Figure 4. Sitagliptin Features
Figure 5. Saxagliptin Features
Figure 6. Alagliptin Features
Figure 7. Others Features
Figure 8. Global Oral GLP-1 Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral GLP-1 Market Share by Application: 2024 VS 2031
Figure 10. Diabetics Case Studies
Figure 11. Weight Loss People Case Studies
Figure 12. Others Case Studies
Figure 13. Oral GLP-1 Report Years Considered
Figure 14. Global Oral GLP-1 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Oral GLP-1 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Oral GLP-1 Market Share by Region: 2024 VS 2031
Figure 17. Global Oral GLP-1 Market Share by Players in 2024
Figure 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Oral GLP-1 Revenue in 2024
Figure 20. North America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Oral GLP-1 Market Share by Country (2020-2031)
Figure 22. United States Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Oral GLP-1 Market Share by Country (2020-2031)
Figure 26. Germany Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Oral GLP-1 Market Share by Region (2020-2031)
Figure 34. China Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Oral GLP-1 Market Share by Country (2020-2031)
Figure 42. Mexico Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Oral GLP-1 Market Share by Country (2020-2031)
Figure 46. Turkey Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Oral GLP-1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 50. Novo Nordisk Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 52. AstraZeneca Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Oral GLP-1 Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232